(Q53200536)

12 May 2018

title

In vitro stimulation of tissue-type plasminogen activator by Alzheimer amyloid beta-peptide analogues. (English)

1 reference

12 May 2018

1 reference

Kingston IB

1

1 reference

12 May 2018

Castro MJ

series ordinal

2

1 reference

12 May 2018

Anderson S

series ordinal

3

1 reference

12 May 2018

language of work or name

English

0 references

publication date

1 February 1995

1 reference

12 May 2018

published in

Nature Medicine

1 reference

12 May 2018

volume

1

1 reference

12 May 2018

page(s)

138-142

1 reference

12 May 2018

issue

2

1 reference

12 May 2018

https://scigraph.springernature.com/pub.10.1038/nm0295-138

exact match

0 references

cites work

The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor

1 reference

https://api.crossref.org/works/10.1038%2FNM0295-138

Down patients: extracellular preamyloid deposits precede neuritic degeneration and senile plaques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0295-138

Familial cerebral amyloid angiopathy presenting as recurrent cerebral haemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0295-138

Hereditary cerebral haemorrhage caused by cortical amyloid angiopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0295-138

Cerebral amyloid angiopathy. A critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0295-138

Molecular pathology of amyloidogenic proteins and the role of vascular amyloidosis in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0295-138

Antibodies to the beta-amyloid peptide cross-react with conformational epitopes in human fibrinogen subunits from peripheral blood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0295-138

Amyloid beta-peptide is produced by cultured cells during normal metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0295-138

Amyloid beta-protein deposition in tissues other than brain in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0295-138

Cerebral amyloid angiopathy without and with cerebral hemorrhages: a comparative histological study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0295-138

Intracerebral hemorrhage after fibrinolytic therapy for acute myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0295-138

Intracranial hemorrhage after use of tissue plasminogen activator for coronary thrombolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0295-138

Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0295-138

7 January 2021

Amyloid plaque core protein in Alzheimer disease and Down syndrome

1 reference

https://api.crossref.org/works/10.1038%2FNM0295-138

7 January 2021

Hereditary cerebral hemorrhage with amyloidosis in patients of Dutch origin is related to Alzheimer disease

1 reference

https://api.crossref.org/works/10.1038%2FNM0295-138

7 January 2021

Differences between vascular and plaque core amyloid in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038%2FNM0295-138

7 January 2021

Molecular cloning and characterization of a cDNA encoding the cerebrovascular and the neuritic plaque amyloid peptides

1 reference

https://api.crossref.org/works/10.1038%2FNM0295-138

7 January 2021

Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type.

1 reference

https://api.crossref.org/works/10.1038%2FNM0295-138

7 January 2021

An immunoperoxidase study of senile cerebral amyloidosis with pathogenetic considerations

1 reference

https://api.crossref.org/works/10.1038%2FNM0295-138

7 January 2021

A spectrophotometric assay for the determination of the catalytic efficiency of plasminogen activators using a slowly hydrolyzed plasmin substrate

1 reference

https://api.crossref.org/works/10.1038%2FNM0295-138

7 January 2021

The influence of fibrin(ogen) fragments on the kinetic parameters of the tissue-type plasminogen-activator-mediated activation of different forms of plasminogen

1 reference

https://api.crossref.org/works/10.1038%2FNM0295-138

7 January 2021

The effect of the one-chain to two-chain conversion in tissue plasminogen activator: characterization of mutations at position 275

1 reference

https://api.crossref.org/works/10.1038%2FNM0295-138

7 January 2021

Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state

1 reference

https://api.crossref.org/works/10.1038%2FNM0295-138

7 January 2021

Fibril formation by primate, rodent, and Dutch-hemorrhagic analogues of Alzheimer amyloid beta-protein

1 reference

https://api.crossref.org/works/10.1038%2FNM0295-138

7 January 2021

Interaction of plasminogen activators and inhibitors with plasminogen and fibrin

1 reference

https://api.crossref.org/works/10.1038%2FNM0295-138

7 January 2021

Intracerebral hemorrhage related to cerebral amyloid angiopathy and t-PA treatment

1 reference

https://api.crossref.org/works/10.1038%2FNM0295-138

7 January 2021

Identifiers

DOI

10.1038/NM0295-138

1 reference

12 May 2018

PubMed ID

7585010

1 reference

12 May 2018